Skip to content
BidBenchmark

NAICS code

Research and Development in Biotechnology

NAICS code
541711
Latest action
Aug 25, 2026
Median award value
Not published

Fewer than the minimum comparable awards under this NAICS code.

Awards
881
Contractors
64

Largest awards under this code

AwardContractorAgencyPlaceFirst actionCurrent value
DEAC3608GO28308

AWARD OF CONTRACT TO MANAGE AND OPERATE THE NATIONAL RENEWABLE ENERGY LABORATORY

ALLIANCE FOR ENERGY INNOVATION, LLCDepartment of EnergyCOJul 29, 2008$13,300,000,000
HHSO100201600030C

IGF::OT::IGF

EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.Department of Health and Human ServicesMDSep 30, 2016$1,409,725,727
HHSO100201700016C

IGF::OT::IGF

REGENERON PHARMACEUTICALS INCDepartment of Health and Human ServicesNYSep 28, 2017$695,741,476
W911QY13C0056

TERMINATION SETTLEMENT PROPOSAL DEADLINE FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.

DYNPORT VACCINE COMPANY LLCDepartment of DefenseMDMar 26, 2026$257,417,661
HHSO100201700012C

IGF::OT::IGF

MERCK SHARP & DOHME LLCDepartment of Health and Human ServicesNJSep 28, 2017$236,307,634
HHSO100201600009C

THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE FUNDS FROM CLIN 0011 (OPTION 10) AND UPDATE FAR & HHSAR CLAUSES PER EXECUTIVE ORDER AND FAR/HHSAR CLASS DEVIATIONS

CERUS CORPORATIONDepartment of Health and Human ServicesCAMay 18, 2026$197,476,020
HHSO100201600038C

IGF::OT::IGF HOFFMANN-LAROCHE INC.

HOFFMANN-LA ROCHE INC.Department of Health and Human ServicesNJSep 15, 2016$183,844,128
HHSO100201500029C

THE PURPOSE OF MODIFICATION P00014 IS TO DE-OBLIGATE CANCELING FUNDS

PFIZER INCDepartment of Health and Human ServicesMay 12, 2026$93,359,027
HHSO100201100013C

THE PURPOSE OF THIS MODIFICATION IS TO CLOSE OUT THE CONTRACT IN ITS ENTIRETY. 1. CHIMERIX IS NO LONGER IN OPERATION AND THEREFORE, THIS CONTRACT CAN BE DEOBLIGATED AND CLOSED OUT IN ITS ENTIRETY. NO CONTRACTOR RELEASE OF CLAIMS NOR A CONTRACTING O

CHIMERIX, INC.Department of Health and Human ServicesNCMay 18, 2026$77,076,622
HHSN275201700002C

DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT

THE EMMES COMPANY, LLCDepartment of Health and Human ServicesMDMay 27, 2026$66,041,065
HHSO100201100037C

ADVANCEMENT OF HEMAMAX TOWARDS BLA SUBMISSION FOR THE MITIGATION OF HSARS UNDER THE FDA ANIMAL RULE

NEUMEDICINES INC.Department of Health and Human ServicesCASep 15, 2011$54,163,469
HHSN272201600029C

IGF::OT::IGF - ORALLY BIOAVAILABLEβ-LACTAM/β-LACTAMASE INHIBITOR COMBINATION FOR BIODEFENSE AND PUBLIC HEALTH.

VENATORX PHARMACEUTICALS INCDepartment of Health and Human ServicesPASep 19, 2016$48,517,079
HHSN272201400005C

IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

UNIVERSITY OF ROCHESTERDepartment of Health and Human ServicesNYJan 9, 2014$37,266,757
HHSO100201000008C

THE PURPOSE OF THIS NO MODIFICATION IS TO CLOSE OUT CONTRACT NO. HHSO100201000008C IN ITS ENTIRETY.

ARIZONA STATE UNIVERSITYDepartment of Health and Human ServicesAZJul 6, 2026$34,685,397
HHSN272201200004C

TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTER

PPD DEVELOPMENT LPDepartment of Health and Human ServicesNCDec 16, 2011$27,036,076
W81XWH20F0253

CONTRACTOR-ACQUIRED PROPERTY (CAP) AND GOVERNMENT FURNISHED EQUIPMENT

INBIOS INTERNATIONAL INCDepartment of DefenseWAMar 10, 2026$25,655,995
HHSN272201700085C

IGF::OT::IGF DIVISION OF MICROBIOLOGY AND INFECTIOUS DISEASES (DMID) CLINICAL MATERIALS SERVICES

FISHER BIOSERVICES INCDepartment of Health and Human ServicesMDSep 11, 2017$24,948,662
HHSN272201700059C

TO ADMINISTRATE DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.

SEATTLE CHILDREN'S HOSPITALDepartment of Health and Human ServicesWAJul 21, 2026$24,736,446
W81XWH15C0048

THIS REQUIREMENT IS FOR COMMERCIALIZATION OF FREEZE DRIED PLASMA PRODUCT.

WESTAT, INC.Department of DefenseMDMar 2, 2026$23,174,896
HHSN271201600048C

IGF::OT::IGF OTHER FUNCTIONS NINDS EPILEPSY THERAPY SCREENING PROGRAM

UNIVERSITY OF UTAHDepartment of Health and Human ServicesUTSep 26, 2016$22,343,504
HHSN272201200002C

R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)

PPD DEVELOPMENT LPDepartment of Health and Human ServicesNCNov 1, 2011$22,043,479
HHSO100201000035C

TAS::75 0140::TAS CLINICAL TRIAL IN A TEST TUBE FOR MEDICAL COUNTERMEASURE DEVELOPMENT

SANOFI PASTEUR VAXDESIGN CORPDepartment of Health and Human ServicesFLJul 30, 2010$16,925,701
HHSO100201700026C

THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE CANCELLING FUNDS IN THE AMOUNT OF $2,539,496.23 AS FOLLOWS: 1. $1,050,656.17 FROM CLIN 0013 2. $1,488,840.00 FROM CLIN 0014 3. $0.06 FROM CLIN 0012

NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Health and Human ServicesNJJul 8, 2026$16,334,775
HDTRA117C0070

NEW PBP INHIBITORS IMPERVIOUS TO BETA-LACTAMASES

VENATORX PHARMACEUTICALS INCDepartment of DefensePAApr 30, 2026$14,716,733
HHSO100201700029C

IGF::OT::IGF - BASE PERIOD AWARD TO INBIOS INTERNATIONAL, INC. FOR POINT-OF-CARE IMMUNOASSAY FOR DIAGNOSIS OF INHALATIONAL ANTHRAX

INBIOS INTERNATIONAL INCDepartment of Health and Human ServicesWASep 18, 2017$12,051,614

Related records

Derived from awards these records share, ordered by how many.

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

Totals cover awards where the government recorded this NAICS code. Codes are taken as reported; awards are never reclassified into a different code.

  1. 1Awards are grouped by the NAICS code the government recorded on the award, taken from USAspending.gov and last refreshed Aug 27, 2026. Miscoded awards stay miscoded here; we do not reassign codes.
NAICS 541711 — Research and Development in Biotechnology federal contracts · BidBenchmark